Ocular Immunology and Inflammation 2011-02-01

Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis.

Paul A Kurz, Lena V Chheda, Daryl E Kurz

Index: Ocul. Immunol. Inflamm. 19(1) , 84-5, (2011)

Full Text: HTML

Abstract

To report the effects of twice-daily difluprednate in a child with pars planitis (PP).Case report.PP was controlled with topical difluprednate for 1 year. Then an atypical pattern of steroid response--delayed, relatively sudden onset of recalcitrant ocular hypertension (OHT)--and posterior subcapsular cataract (PSC) formation necessitated alternative treatment.Although not a standard treatment, in select cases of PP topical difluprednate therapy could be a useful short-term treatment option while alternative treatments are considered or immunosuppressive agents build to therapeutic levels. Ophthalmologists must be aware of the potential for delayed onset of serious complications when using difluprednate.

Related Compounds

  • Difluprednate

Related Articles:

Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation.

2014-09-01

[Eye Contact Lens 40(5) , 283-8, (2014)]

Determination of natural and synthetic glucocorticoids in effluent of sewage treatment plants using ultrahigh performance liquid chromatography-tandem mass spectrometry.

2015-09-01

[Environ. Sci. Pollut. Res. Int. 22 , 14127-35, (2015)]

Pharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassay.

2011-02-01

[J. Ocul. Pharmacol. Ther. 27(1) , 29-34, (2011)]

Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.

2014-05-01

[Invest. Ophthalmol. Vis. Sci. 55(5) , 2993-3002, (2014)]

Analysis of an anti-inflammatory steroidal drug, difluprednate, in aqueous humor by combination of semi-micro HPLC and column switching method.

2003-01-15

[J. Pharm. Biomed. Anal. 30(6) , 1735-42, (2003)]

More Articles...